Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Immune Design and Merck & Co. collaborate to study immunotherapies with Keytruda

Aug. 12, 2015

Phase I study investigates ADCT-301 for relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

Aug. 12, 2015

Phase I study investigates DNA vaccine pTVG-AR for metastatic prostate cancer

Aug. 11, 2015

Inovio and MedImmune establish cancer vaccine collaboration

Aug. 11, 2015

MabVax and Rockefeller University enter into research collaboration agreement

Aug. 11, 2015

The FDA grants orphan drug designation to daratumumab for follicular lymphoma

Aug. 10, 2015

FDA approves IND application for Valor's IGN-002

Aug. 7, 2015

Advaxis receives prostate cancer charity grants to develop ADXS-PSA

Aug. 7, 2015

MedImmune and Mirati to conduct trial combining durvalumab and mocetinostat

Aug. 5, 2015

Anti-GD2 antibody enters phase II trial in osteosarcoma

Aug. 3, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026